Skip to main content
Premium Trial:

Request an Annual Quote

23andMe Gains FDA Clearance for Direct-to-Consumer Prostate Cancer Genetic Risk Test

NEW YORK – 23andMe said Monday that it has received 510(k) clearance from the US Food and Drug Administration for a direct-to-consumer genetic risk report for hereditary prostate cancer that is based on the HOXB13 marker.

The test looks for the G84E variant, which is most prevalent in individuals of Northern European ancestry. Between 33 percent and 53 percent of men who carry the variant develop prostate cancer during their lifetime, compared to 12 percent of men in the general population.

This is 23andMe's third FDA clearance for a cancer risk report. The genetic testing firm previously passed 510(k) reviews for its MUTYH-associated polyposis report for hereditary colorectal cancer and another for three BRCA1/BRCA2 mutations, and said that it is the only company with multiple FDA clearances for DTC genetic health reports.

The Sunnyvale, California-based company has not yet released the HOXB13 test to market but said that it will be offered as an add-on to customers of its Health + Ancestry Service who have been genotyped on the firm's most recent platform.

"These reports provide our customers with the knowledge that they might be at risk for certain diseases, including hereditary cancers, empowering them to take appropriate preventative action with their healthcare provider," cofounder and CEO Anne Wojcicki said in a statement.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.